Novel Imaging Probes: From Design to Applications

Overview

Journal Pharmaceuticals (Basel)

Publisher MDPI

Specialty Chemistry

Date 2023 Oct 28

PMID 37895977

Authors

Kuo-Ting Chen

Affiliations

Soon will be listed here.

Abstract

Molecular imaging has emerged as a powerful tool for clinical diagnosis [...].

References

Handula M, Chen K, Seimbille Y . IEDDA: An Attractive Bioorthogonal Reaction for Biomedical Applications. Molecules. 2021; 26(15). PMC: 8347371. DOI: 10.3390/molecules26154640. View

Loktev A, Lindner T, Mier W, Debus J, Altmann A, Jager D . A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts. J Nucl Med. 2018; 59(9):1423-1429. PMC: 6126438. DOI: 10.2967/jnumed.118.210435. View

Chen K, Chen X . Design and development of molecular imaging probes. Curr Top Med Chem. 2010; 10(12):1227-36. PMC: 3632640. DOI: 10.2174/156802610791384225. View

Bredack C, Edelmann M, Borroni E, Gobbi L, Honer M . Antibody-Based In Vivo Imaging of Central Nervous System Targets-Evaluation of a Pretargeting Approach Utilizing a TCO-Conjugated Brain Shuttle Antibody and Radiolabeled Tetrazines. Pharmaceuticals (Basel). 2022; 15(12). PMC: 9787164. DOI: 10.3390/ph15121445. View

Laurene W, Raul L, Katalin S, Celine F, Gilles K, Antonio M . Design and synthesis of a new bifunctional chelating agent: Application for Al F/Lu complexation. J Inorg Biochem. 2023; 246:112267. DOI: 10.1016/j.jinorgbio.2023.112267. View

Zeng D, Zeglis B, Lewis J, Anderson C . The growing impact of bioorthogonal click chemistry on the development of radiopharmaceuticals. J Nucl Med. 2013; 54(6):829-32. PMC: 4151560. DOI: 10.2967/jnumed.112.115550. View

Ahenkorah S, Murce E, Cawthorne C, Pougoue Ketchemen J, Deroose C, Cardinaels T . 3p-C-NETA: A versatile and effective chelator for development of AlF-labeled and therapeutic radiopharmaceuticals. Theranostics. 2022; 12(13):5971-5985. PMC: 9373814. DOI: 10.7150/thno.75336. View

Jansen K, Heirbaut L, Verkerk R, Cheng J, Joossens J, Cos P . Extended structure-activity relationship and pharmacokinetic investigation of (4-quinolinoyl)glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP). J Med Chem. 2014; 57(7):3053-74. DOI: 10.1021/jm500031w. View

Jovcevska I, Muyldermans S . The Therapeutic Potential of Nanobodies. BioDrugs. 2019; 34(1):11-26. PMC: 6985073. DOI: 10.1007/s40259-019-00392-z. View

10.

Bauer D, Cornejo M, Hoang T, Lewis J, Zeglis B . Click Chemistry and Radiochemistry: An Update. Bioconjug Chem. 2023; 34(11):1925-1950. PMC: 10655046. DOI: 10.1021/acs.bioconjchem.3c00286. View

11.

Zhong X, Yan J, Ding X, Su C, Xu Y, Yang M . Recent Advances in Bioorthogonal Click Chemistry for Enhanced PET and SPECT Radiochemistry. Bioconjug Chem. 2023; 34(3):457-476. DOI: 10.1021/acs.bioconjchem.2c00583. View

12.

Edelmann M, Bredack C, Belli S, Mohr P, Imhoff M, Reggiani F . Evaluation of Tetrazine Tracers for Pretargeted Imaging within the Central Nervous System. Bioconjug Chem. 2023; 34(10):1882-1893. DOI: 10.1021/acs.bioconjchem.3c00385. View

13.

Rosar F, Hau F, Bartholoma M, Maus S, Stemler T, Linxweiler J . Molecular imaging and biochemical response assessment after a single cycle of [Ac]Ac-PSMA-617/[Lu]Lu-PSMA-617 tandem therapy in mCRPC patients who have progressed on [Lu]Lu-PSMA-617 monotherapy. Theranostics. 2021; 11(9):4050-4060. PMC: 7977444. DOI: 10.7150/thno.56211. View

14.

Pleiner T, Bates M, Trakhanov S, Lee C, Schliep J, Chug H . Nanobodies: site-specific labeling for super-resolution imaging, rapid epitope-mapping and native protein complex isolation. Elife. 2015; 4:e11349. PMC: 4755751. DOI: 10.7554/eLife.11349. View

15.

Jansen K, Heirbaut L, Cheng J, Joossens J, Ryabtsova O, Cos P . Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold. ACS Med Chem Lett. 2014; 4(5):491-6. PMC: 4027141. DOI: 10.1021/ml300410d. View